[go: up one dir, main page]

ES2127469T3 - Composiciones dermatologicas que contienen una sal del acido lactico. - Google Patents

Composiciones dermatologicas que contienen una sal del acido lactico.

Info

Publication number
ES2127469T3
ES2127469T3 ES95301863T ES95301863T ES2127469T3 ES 2127469 T3 ES2127469 T3 ES 2127469T3 ES 95301863 T ES95301863 T ES 95301863T ES 95301863 T ES95301863 T ES 95301863T ES 2127469 T3 ES2127469 T3 ES 2127469T3
Authority
ES
Spain
Prior art keywords
lactic acid
salt
compositions containing
dermatological compositions
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95301863T
Other languages
English (en)
Inventor
Prakash Parab
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22805195&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2127469(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ES2127469T3 publication Critical patent/ES2127469T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

UNA COMPOSICION CON UN INDICE INCREMENTADO DE PERMEABILIDAD ACIDO LACTICA EN LA PIEL PARA EL TRATAMIENTO DE DESORDENES DERMATOLOGICOS, Y QUE CONTIENE UNA SAL ORGANICA O INORGANICA O ACIDO LACTICO EN UNA COMPOSICION DERMATOLOGICAMENTE ACEPTABLE, DONDE AL MENOS EL 70% DE LA MITAD DEL ACIDO LACTICO EN LA SAL ES ACIDO L-LACTICO, Y UN METODO QUE UTILIZA DICHA COMPOSICION.
ES95301863T 1994-03-22 1995-03-21 Composiciones dermatologicas que contienen una sal del acido lactico. Expired - Lifetime ES2127469T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21598594A 1994-03-22 1994-03-22

Publications (1)

Publication Number Publication Date
ES2127469T3 true ES2127469T3 (es) 1999-04-16

Family

ID=22805195

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95301863T Expired - Lifetime ES2127469T3 (es) 1994-03-22 1995-03-21 Composiciones dermatologicas que contienen una sal del acido lactico.

Country Status (9)

Country Link
US (2) US5702711A (es)
EP (1) EP0673647B1 (es)
JP (1) JPH07258077A (es)
AU (1) AU701122B2 (es)
CA (1) CA2143515A1 (es)
DE (1) DE69507843T2 (es)
DK (1) DK0673647T3 (es)
ES (1) ES2127469T3 (es)
NZ (1) NZ270738A (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5420106A (en) * 1994-03-22 1995-05-30 Bristol-Myers Squibb Company Method and composition having enhanced alpha-hydroxy acid skin permeation and retention
DE4432429A1 (de) * 1994-09-12 1996-03-14 Heinz Prahm Arzneimittel enthaltend S-Milchsäure und dessen Verwendung
JP3276871B2 (ja) * 1997-02-12 2002-04-22 花王株式会社 ヘアーコンディショニング剤組成物
US6353029B1 (en) * 2000-08-24 2002-03-05 Bristol-Myers Squibb Company Storage stable tretinoin and 4-hydroxyanisole containing topical composition
AU2002314847A1 (en) * 2001-05-31 2002-12-09 Upsher-Smith Laboratories, Inc. Dermatological compositions and methods comprising alpha-hydroxy acids or derivatives
JP2003026592A (ja) * 2001-07-09 2003-01-29 Nippon Hypox Lab Inc 甘草発酵抽出物からなる抗アンドロゲン剤
US20060269495A1 (en) * 2005-05-25 2006-11-30 Popp Karl F Alpha hydroxy acid compositions
US8784861B2 (en) * 2005-06-15 2014-07-22 Poly-Med, Inc. Swellable fiber- and microfiber-forming polyether-esters and applications thereof
US8927001B2 (en) * 2005-06-15 2015-01-06 Poly-Med, Inc. Bioswellable, crystalline, amphiphilic, block/graft polymers and applications thereof
WO2009155118A1 (en) * 2008-05-30 2009-12-23 Reprotect, Inc. Compositions and methods for inactivation of pathogens at genital tract surfaces
US9155873B2 (en) 2011-05-17 2015-10-13 Reprotect, Inc. Reusable intravaginal delivery device, system, and method
US20140112959A1 (en) 2012-10-18 2014-04-24 MiCal Pharmaceuticals LLC - H Series, a Series of MiCal Pharmaceuticals LLC, a Multi-Division Limite Topical steroid composition and method
US10463636B2 (en) * 2016-09-30 2019-11-05 Deanna J. Nelson Pharmaceutical quality strontium L-lactate
CN116459241A (zh) * 2022-01-11 2023-07-21 长春圣博玛生物材料有限公司 乳酸在调节促进组织增长制品中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4363815A (en) * 1975-07-23 1982-12-14 Yu Ruey J Alpha hydroxyacids, alpha ketoacids and their use in treating skin conditions
US4021572A (en) * 1975-07-23 1977-05-03 Scott Eugene J Van Prophylactic and therapeutic treatment of acne vulgaris utilizing lactamides and quaternary ammonium lactates
BR7904612A (pt) * 1978-07-24 1980-04-08 Unilever Nv Composicao cosmeticamente aceitavel para aplicacao topica,processo para preparar uma composicao,aplicador e processopara prover vantagem a pele
US4285964A (en) * 1979-08-30 1981-08-25 Continental Pharma Salts of (+)-catechine, their preparation and use, and compositions containing these salts
US4360523A (en) * 1980-05-16 1982-11-23 Bristol-Myers Company Pharmaceutical formulations of 4'-(9-acridinylamino)-methanesulfon-m-anisidide
US4863506A (en) * 1983-07-06 1989-09-05 Union Oil Company Of California Methods for regulating the growth of plants and growth regulant compositions
US5091171B2 (en) * 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
US5100918A (en) * 1989-05-25 1992-03-31 Sterling Drug, Inc. Prevention or treatment of sunburn using the S(+) isomer of ibuprofen
JP2593714B2 (ja) * 1989-09-20 1997-03-26 株式会社 林原生物化学研究所 色白剤
US5254343A (en) * 1991-03-19 1993-10-19 Bristol-Myers Squibb Company Reduction of cutaneous atrophy
CA2161525A1 (en) * 1993-07-26 1995-02-02 John Bartolone Cosmetic composition

Also Published As

Publication number Publication date
EP0673647A1 (en) 1995-09-27
AU701122B2 (en) 1999-01-21
US5705168A (en) 1998-01-06
DE69507843D1 (de) 1999-03-25
JPH07258077A (ja) 1995-10-09
US5702711A (en) 1997-12-30
DK0673647T3 (da) 1999-09-20
DE69507843T2 (de) 1999-10-07
AU1497695A (en) 1995-09-28
CA2143515A1 (en) 1995-09-23
EP0673647B1 (en) 1999-02-17
NZ270738A (en) 1997-05-26

Similar Documents

Publication Publication Date Title
US5091171B1 (en) Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use
ES2127469T3 (es) Composiciones dermatologicas que contienen una sal del acido lactico.
ES2123910T3 (es) Composiciones que contienen sales anfoteras de alfa-hidroxiacidos y monocaprilato de glicerol.
DE59305359D1 (de) Desodorierende kosmetische zubereitungen mit einem gehalt an di- oder triglycerinestern
DE59508891D1 (de) Hautpflegemittel
IL130083A0 (en) 3-Pyridyl enantiomers and their use as analgesics
IT8567279A1 (it) Apparecchio per l'applicazione controllata, sul tessuto umano, di sostanze riducenti per realizzare microabrasioni.
AR014438A1 (es) Metodo cosmetico para reducir el crecimiento del pelo estimulado por androgenos en mamiferos; metodo cosmetico para incrementar el crecimiento delpelo en mamiferos; uso de un compuesto, que induce o activa a una udp-glucuronosiltransferasa o una sulfotransferasa, la conjugacion de un
EP0680328A1 (en) KETOCONAZOLE COMPOSITIONS FOR LOCAL USE.
ES8609279A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1,2,3-triazol.
DE3485488D1 (de) Imidazoliumsalze, zwischenprodukte fuer ihre herstellung sowie ihre verwendung.
DE69130497D1 (de) Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
PL324625A1 (en) Fungicidal compositions
FI851261A0 (fi) Substituerade bensopyraner, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
PT100638A (pt) Metodo para evitar e tratar a alopecia induzida por quimioterapia
ATE227973T1 (de) Kosmetische, dermatologische und pharmazeutische anwendung eines terminalia catappa pflanzenextrakts
NZ308260A (en) Use of 5-(substituted biphenyl)-tetrazole derivatives to treat multiple system organ failure
JPS5714517A (en) Whitening cosmetic
DE3687838D1 (de) Deodorant-bettmaterial.
DE69314463D1 (de) Hautregenerierende kosmetische zusammensetzung
ATE101045T1 (de) Verwendung von zink-calciumhydroxid, lecithin und pao zur adjuvierung von antigenloesungen und auf diese weise adjuvierte antigenloesungen.
DE69300888D1 (de) Feuchtigkeitsspendende kosmetische Zubereitungen.
ATE45853T1 (de) Mikroorganismen toetende oder das wachstum von mikroorganismen hemmende zusammensetzung und deren verwendung.
PT91415A (pt) Processo para a preparacao de novos derivados de furiltiazol
MX9302818A (es) Agente para incrementar somatostatina o para inhibir la reduccion de somatostatina.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 673647

Country of ref document: ES